1. Therapeutic drug monitoring in HIV infection: current status and future directions
2. 2S Kaul, K Bassi, and B Damle , et al.Pharmacokinetic evaluation of the combination of atazinavir (ATV), enteric coated didanosine (ddI-EC), and tenofovir disoproxil fumurate (TDF) for a once-daily antiretroviral regime . 43rd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy.Chicago, 2003 , Abstract A-1616.
3. 4J Poirier, J Meynard, J Guiard-Schmid, P Girard, W Rozenbaum, and P Jaillon . Lack of alteration of lopinavir and ritonavir trough plasma concentrations in HIV-experienced patients treated with Kaletra and tenofovir DF . 42nd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy.San Diego, 2002 , Abstract H-1715.
4. Clinical Pharmacokinetics of the Antiviral Nucleotide Analogues Cidofovir and Adefovir